(Q44161304)

30 November 2017

title

Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats (English)

1 reference

30 November 2017

0 references

Yangzheng Feng

1

1 reference

30 November 2017

John E Piletz

series ordinal

2

1 reference

30 November 2017

Michael H Leblanc

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

52

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

606-611

1 reference

https://scigraph.springernature.com/pub.10.1203/00006450-200210000-00023

30 November 2017

exact match

0 references

cites work

Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat.

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Agmatine: an endogenous clonidine-displacing substance in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Characterization of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Is agmatine a novel neurotransmitter in brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Biological effects of arginine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Biological significance of agmatine, an endogenous ligand at imidazoline binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Agmatine improves locomotor function and reduces tissue damage following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Reduction of perinatal hypoxic-ischemic brain damage with allopurinol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Sensorimotor function and neuropathology five to six weeks after hypoxia-ischemia in seven-day-old rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Nitric oxide synthase in models of focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Mechanisms of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

Hypoxic-ischemic injury in the neonatal rat brain: effects of pre-and post-treatment with the glutamate release inhibitor BW1003C87

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2F00006450-200210000-00023

10.1203/00006450-200210000-00023

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 November 2017

1013893315

0 references

1 reference